{
  "id": "pad",
  "name": "Peripheral Arterial Disease (PAD)",
  "category": ["Vascular"],
  "clinical_triggers": {
    "symptoms_any": [
      "Claudication (exertional leg pain relieved by rest)",
      "Rest pain (advanced)",
      "Non-healing wounds",
      "Blue toe"
    ],
    "signs_any": [
      "Diminished pulses",
      "Bruits",
      "Cool skin, hair loss",
      "Dependent rubor",
      "Ulceration/gangrene"
    ]
  },
  "initial_tests": [
    "Ankle-brachial index (ABI): PAD if â‰¤0.90",
    "Toe-brachial index for diabetics or non-compressible vessels",
    "Exercise ABI if symptoms and normal resting ABI",
    "Duplex ultrasound for anatomic assessment; CTA/MRA when planning revascularization"
  ],
  "risk_factors": [
    "Smoking",
    "Diabetes",
    "Hyperlipidemia",
    "Hypertension",
    "CKD",
    "Age",
    "CAD/CVD"
  ],
  "treatment": {
    "all_patients_initial": [
      "Smoking cessation",
      "Supervised exercise therapy program",
      "High-intensity statin",
      "Antiplatelet therapy (aspirin or clopidogrel)",
      "Optimize BP, diabetes; consider SGLT2i/GLP-1 RA for CV benefit in DM"
    ],
    "claudication_pharmacotherapy": [
      "Cilostazol improves walking distance (avoid in HFrEF)"
    ],
    "revascularization": [
      "Endovascular or surgical revascularization for lifestyle-limiting claudication refractory to therapy or critical limb-threatening ischemia"
    ]
  },
  "contraindications": {
    "cilostazol": ["Avoid in HFrEF"]
  },
  "follow_up": [
    "Foot care education, wound surveillance in high-risk patients",
    "ABI surveillance after revascularization per protocol"
  ],
  "discharge": {
    "instructions": [
      "Daily foot inspection, protective footwear",
      "Adherence to exercise therapy and medications"
    ],
    "follow_up": ["Vascular/cardiology follow-up; wound care as needed"]
  }
}
